Megostat 40 mg/ml oralna suspenzija
Name | Megostat 40 mg/ml oralna suspenzija |
---|---|
Marketing Authorisation Number | HR-H-142933667 |
Active Substance | megestrolacetat |
Composition | 1 ml suspenzije sadrži 40 mg mikroniziranog megestrolacetata |
Pharmaceutical Form | oralna suspenzija |
Manufacturer | Bausch Health Poland sp. z o.o., Rzeszow, Poljska Bausch Health Poland sp. z o.o., Mysłowice, Poljska |
Marketing Authorisation Holder | Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
Marketing Authorisation Date | 10.03.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/166 |
Registration Number | 381-12-01/70-20-31 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | L02AB01 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |